United States Biotechnology & Medical Research

GeoVax Labs Inc (GOVX)

Track

Track

GeoVax Labs Inc has seen consistent insider buying activity, with the most recent transaction occurring on October 17, 2025. Executives and other insiders have exclusively purchased shares over the observed period, reflecting a pattern of accumulation. No sales were recorded, indicating a sustained interest from leadership in increasing their equity stakes.
Ticker: GOVX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for GeoVax Labs Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.0
SPENCER JOHN N JR Non-Executive Director
Transaction date
Purchase
Price
383.34
Quantity 11,227 -23.6%
Value US$4,433,851
3.6
McKee Kelly T. Jr. Chief Medical Officer Officer
Transaction date
Purchase
Price
49.91
Quantity 56,139 -41.5%
Value US$2,526,620
1.0
SPENCER JOHN N JR Non-Executive Director
Transaction date
Purchase
Price
331.70
Quantity 25,807 +17.7%
Value US$613,628
1.9
Sharkey John W. VP, Business Development Officer
Transaction date
Purchase
Price
0.99
Quantity 6,000 +3141.4%
Value US$5,940
2.6
DODD DAVID A President, CEO Executive Director
Transaction date
Purchase
Price
1.08
Quantity 10,000 +37.5%
Value US$10,800
1.9
Reynolds Mark CFO Officer
Transaction date
Purchase
Price
1.08
Quantity 6,800 +94.3%
Value US$7,343
2.6
DODD DAVID A President, CEO Executive Director
Transaction date
Purchase
Price
1.95
Quantity 8,000 +42.9%
Value US$15,600
2.6
DODD DAVID A President, CEO Executive Director
Transaction date
Purchase
Price
2.27
Quantity 8,209 +78.5%
Value US$18,663
2.6
DODD DAVID A President, CEO Executive Director
Transaction date
Purchase
Price
2.15
Quantity 520 +5.2%
Value US$1,118
1.9
Reynolds Mark CFO Officer
Transaction date
Purchase
Price
2.77
Quantity 2,000 +38.4%
Value US$5,540
3.6
McKee Kelly T. Jr. Chief Medical Officer Officer
Transaction date
Purchase
Price
0.36
Quantity 6,944 +24.1%
Value US$2,500
3.6
McKee Kelly T. Jr. Chief Medical Officer Officer
Transaction date
Purchase
Price
0.52
Quantity 9,653 +50.3%
Value US$5,020
2.6
DODD DAVID A President, CEO Executive Director
Transaction date
Purchase
Price
0.57
Quantity 35,087 +30.8%
Value US$20,000
1.9
Reynolds Mark CFO Officer
Transaction date
Purchase
Price
0.52
Quantity 10,000 +14.7%
Value US$5,179
2.6
DODD DAVID A President, CEO Executive Director
Transaction date
Purchase
Price
0.64
Quantity 32,000 +39.1%
Value US$20,445
1.9
Reynolds Mark CFO Officer
Transaction date
Purchase
Price
0.63
Quantity 8,000 +13.3%
Value US$5,040
1.2
CHASE RANDAL D Non-Executive Director
Transaction date
Purchase
Price
1.10
Quantity 10,000 +37.6%
Value US$11,000
1.9
Sharkey John W. VP, Business Development Officer
Transaction date
Purchase
Price
0.82
Quantity 1,000 +53.8%
Value US$820
3.6
McKee Kelly T. Jr. Chief Medical Officer Officer
Transaction date
Purchase
Price
1.12
Quantity 4,464 +30.3%
Value US$5,000
1.2
CHASE RANDAL D Non-Executive Director
Transaction date
Purchase
Price
1.21
Quantity 10,000 +60.2%
Value US$12,100
3.6
McKee Kelly T. Jr. Chief Medical Officer Officer
Transaction date
Purchase
Price
0.72
Quantity 9,722 +194.5%
Value US$7,000
3.6
McKee Kelly T. Jr. Chief Medical Officer Officer
Transaction date
Purchase
Price
0.71
Quantity 4,999 +inf%
Value US$3,549
1.2
CHASE RANDAL D Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 16,613 +inf%
Value US$83,065
MCNALLY ROBERT T Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 53,925 +inf%
Value US$269,625
1.9
Reynolds Mark CFO Officer
Transaction date
Purchase
Price
5.00
Quantity 60,184 +inf%
Value US$300,920
1.0
SPENCER JOHN N JR Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 21,024 +inf%
Value US$105,120
Kollintzas Dean G Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 11,987 +inf%
Value US$59,935
2.6
DODD DAVID A President, CEO Executive Director
Transaction date
Purchase
Price
5.00
Quantity 81,870 +inf%
Value US$409,350
CHASE RANDAL D Non-Executive Director
Transaction date
Purchase
Price
0.19
Quantity 200 +0.5%
Value US$38
CHASE RANDAL D Non-Executive Director
Transaction date
Purchase
Price
0.19
Quantity 9,800 +32.7%
Value US$1,862
Reynolds Mark CFO Officer
Transaction date
Purchase
Price
0.18
Quantity 10,000 +17.9%
Value US$1,780
Reynolds Mark CFO Officer
Transaction date
Purchase
Price
0.17
Quantity 10,000 +21.7%
Value US$1,735
Reynolds Mark CFO Officer
Transaction date
Purchase
Price
0.17
Quantity 10,000 +27.8%
Value US$1,700
SPENCER JOHN N JR Non-Executive Director
Transaction date
Purchase
Price
0.17
Quantity 18,000 +62.9%
Value US$3,015
CHASE RANDAL D Non-Executive Director
Transaction date
Purchase
Price
0.17
Quantity 30,000 +inf%
Value US$5,100
Reynolds Mark CFO Officer
Transaction date
Purchase
Price
0.67
Quantity 15,000 +71.4%
Value US$10,050
Antebi Steven S. Non-Executive Director
Transaction date
Purchase
Price
0.67
Quantity 30,000 +inf%
Value US$20,100
MCNALLY ROBERT T President/CEO Executive Director
Transaction date
Purchase
Price
0.67
Quantity 29,850 +inf%
Value US$20,000
ROBINSON HARRIET L Chief Scientific Officer Executive Director
Transaction date
Purchase
Price
0.67
Quantity 149,254 +14.2%
Value US$100,000
SPENCER JOHN N JR Non-Executive Director
Transaction date
Purchase
Price
0.67
Quantity 14,925 +108.9%
Value US$10,000
Kollintzas Dean G Non-Executive Director
Transaction date
Purchase
Price
0.67
Quantity 14,925 +inf%
Value US$10,000
Reynolds Mark CFO Officer
Transaction date
Purchase
Price
0.67
Quantity 15,000 +250.0%
Value US$10,050
DODD DAVID A Non-Executive Director
Transaction date
Purchase
Price
0.67
Quantity 112,000 +712.2%
Value US$75,040
Reynolds Mark Chief Financial Officer Officer
Transaction date
Purchase
Price
2.50
Quantity 1,000 +20.0%
Value US$2,500
NEWMAN MARK J VP, Research & Development Officer
Transaction date
Purchase
Price
3.32
Quantity 2,000 +200.0%
Value US$6,640
NEWMAN MARK J VP, Research & Development Officer
Transaction date
Purchase
Price
3.25
Quantity 1,000 +inf%
Value US$3,250
ROBINSON HARRIET L Chief Scientific Officer Executive Director
Transaction date
Purchase
Price
3.35
Quantity 2,100 +0.2%
Value US$7,035
MCNALLY ROBERT T President & CEO Executive Director
Transaction date
Purchase
Price
3.30
Quantity 300 +3.8%
Value US$990
ROBINSON HARRIET L Chief Scientific Officer Executive Director
Transaction date
Purchase
Price
3.30
Quantity 3,000 +0.3%
Value US$9,900
Reynolds Mark Chief Financial Officer Officer
Transaction date
Purchase
Price
3.35
Quantity 530 +11.9%
Value US$1,776
Reynolds Mark Chief Financial Officer Officer
Transaction date
Purchase
Price
3.34
Quantity 570 +14.6%
Value US$1,904
MCNALLY ROBERT T President & CEO Executive Director
Transaction date
Purchase
Price
3.32
Quantity 900 +12.7%
Value US$2,988
Reynolds Mark Chief Financial Officer Officer
Transaction date
Purchase
Price
3.29
Quantity 1,004 +34.7%
Value US$3,303
MCNALLY ROBERT T President & CEO Executive Director
Transaction date
Purchase
Price
3.30
Quantity 100 +1.4%
Value US$330
HILDEBRAND DONALD G Non-Executive Director
Transaction date
Purchase
Price
3.29
Quantity 1,000 +5.6%
Value US$3,290
ROBINSON HARRIET L Chief Scientific Officer Executive Director
Transaction date
Purchase
Price
3.23
Quantity 400 +0.0%
Value US$1,290
DODD DAVID A Non-Executive Director
Transaction date
Purchase
Price
3.25
Quantity 3,702 +30.8%
Value US$12,032
DODD DAVID A Non-Executive Director
Transaction date
Purchase
Price
3.24
Quantity 1,000 +9.1%
Value US$3,240
MCNALLY ROBERT T President & CEO Executive Director
Transaction date
Purchase
Price
3.25
Quantity 1,000 +16.7%
Value US$3,250
ROBINSON HARRIET L Chief Scientific Officer Executive Director
Transaction date
Purchase
Price
3.30
Quantity 3,000 +0.3%
Value US$9,900
ROBINSON HARRIET L Chief Scientific Officer Executive Director
Transaction date
Purchase
Price
3.31
Quantity 500 +0.0%
Value US$1,652
MCNALLY ROBERT T President & CEO Executive Director
Transaction date
Purchase
Price
3.49
Quantity 1,000 +20.0%
Value US$3,490
MCNALLY ROBERT T President & CEO Executive Director
Transaction date
Purchase
Price
4.20
Quantity 1,000 +25.0%
Value US$4,200
DODD DAVID A Non-Executive Director
Transaction date
Purchase
Price
4.00
Quantity 2,900 +35.7%
Value US$11,600
DODD DAVID A Non-Executive Director
Transaction date
Purchase
Price
3.99
Quantity 5,377 +195.8%
Value US$21,454
Tsolinas Peter M Non-Executive Director
Transaction date
Purchase
Price
4.10
Quantity 2,000 +0.5%
Value US$8,200
MCNALLY ROBERT T President & CEO Executive Director
Transaction date
Purchase
Price
3.95
Quantity 1,000 +33.3%
Value US$3,950
DODD DAVID A Non-Executive Director
Transaction date
Purchase
Price
3.70
Quantity 88 +3.3%
Value US$326
Reynolds Mark Chief Financial Officer Officer
Transaction date
Purchase
Price
3.60
Quantity 796 +37.9%
Value US$2,866
DODD DAVID A Non-Executive Director
Transaction date
Purchase
Price
3.60
Quantity 500 +23.2%
Value US$1,800
DODD DAVID A Non-Executive Director
Transaction date
Purchase
Price
3.55
Quantity 459 +27.0%
Value US$1,629
DODD DAVID A Non-Executive Director
Transaction date
Purchase
Price
3.40
Quantity 500 +41.7%
Value US$1,700
DODD DAVID A Non-Executive Director
Transaction date
Purchase
Price
3.39
Quantity 500 +71.5%
Value US$1,695
MCNALLY ROBERT T President & CEO Executive Director
Transaction date
Purchase
Price
3.90
Quantity 1,000 +50.0%
Value US$3,900
SPENCER JOHN N JR Non-Executive Director
Transaction date
Purchase
Price
3.33
Quantity 10,100 +280.6%
Value US$33,633
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-20 2025-10-17 B Purchase
1.0
SPENCER JOHN N JR
Non-Executive Director
11,227 -23.6%
383.34
US$4,433,851 		11,227 -23.6% 383.34 US$4,433,851
2025-08-08 2025-08-07 B Purchase
3.6
McKee Kelly T. Jr.

Chief Medical Officer

Officer
56,139 -41.5%
49.91
US$2,526,620 		56,139 -41.5% 49.91 US$2,526,620
2025-04-11 2025-04-10 B Purchase
1.0
SPENCER JOHN N JR
Non-Executive Director
25,807 +17.7%
331.70
US$613,628 		25,807 +17.7% 331.70 US$613,628
2025-04-10 2025-04-10 B Purchase
1.9
Sharkey John W.

VP, Business Development

Officer
6,000 +3141.4%
0.99
US$5,940 		6,000 +3141.4% 0.99 US$5,940
2025-04-01 2025-04-01 B Purchase
2.6
DODD DAVID A

President, CEO

Executive Director
10,000 +37.5%
1.08
US$10,800 		10,000 +37.5% 1.08 US$10,800
2025-03-31 2025-03-31 B Purchase
1.9
Reynolds Mark

CFO

Officer
6,800 +94.3%
1.08
US$7,343 		6,800 +94.3% 1.08 US$7,343
2024-08-12 2024-08-09 B Purchase
2.6
DODD DAVID A

President, CEO

Executive Director
8,000 +42.9%
1.95
US$15,600 		8,000 +42.9% 1.95 US$15,600
2024-02-22 2024-02-22 B Purchase
2.6
DODD DAVID A

President, CEO

Executive Director
8,209 +78.5%
2.27
US$18,663 		8,209 +78.5% 2.27 US$18,663
2024-02-22 2024-02-21 B Purchase
2.6
DODD DAVID A

President, CEO

Executive Director
520 +5.2%
2.15
US$1,118 		520 +5.2% 2.15 US$1,118
2024-02-07 2024-02-07 B Purchase
1.9
Reynolds Mark

CFO

Officer
2,000 +38.4%
2.77
US$5,540 		2,000 +38.4% 2.77 US$5,540
2023-12-26 2023-12-22 B Purchase
3.6
McKee Kelly T. Jr.

Chief Medical Officer

Officer
6,944 +24.1%
0.36
US$2,500 		6,944 +24.1% 0.36 US$2,500
2023-09-27 2023-09-25 B Purchase
3.6
McKee Kelly T. Jr.

Chief Medical Officer

Officer
9,653 +50.3%
0.52
US$5,020 		9,653 +50.3% 0.52 US$5,020
2023-08-28 2023-08-25 B Purchase
2.6
DODD DAVID A

President, CEO

Executive Director
35,087 +30.8%
0.57
US$20,000 		35,087 +30.8% 0.57 US$20,000
2023-08-21 2023-08-18 B Purchase
1.9
Reynolds Mark

CFO

Officer
10,000 +14.7%
0.52
US$5,179 		10,000 +14.7% 0.52 US$5,179
2023-04-25 2023-04-24 B Purchase
2.6
DODD DAVID A

President, CEO

Executive Director
32,000 +39.1%
0.64
US$20,445 		32,000 +39.1% 0.64 US$20,445
2023-04-21 2023-04-20 B Purchase
1.9
Reynolds Mark

CFO

Officer
8,000 +13.3%
0.63
US$5,040 		8,000 +13.3% 0.63 US$5,040
2022-09-23 2022-09-21 B Purchase
1.2
CHASE RANDAL D
Non-Executive Director
10,000 +37.6%
1.10
US$11,000 		10,000 +37.6% 1.10 US$11,000
2022-07-05 2022-07-01 B Purchase
1.9
Sharkey John W.

VP, Business Development

Officer
1,000 +53.8%
0.82
US$820 		1,000 +53.8% 0.82 US$820
2022-06-28 2022-06-27 B Purchase
3.6
McKee Kelly T. Jr.

Chief Medical Officer

Officer
4,464 +30.3%
1.12
US$5,000 		4,464 +30.3% 1.12 US$5,000
2022-06-22 2022-06-21 B Purchase
1.2
CHASE RANDAL D
Non-Executive Director
10,000 +60.2%
1.21
US$12,100 		10,000 +60.2% 1.21 US$12,100
2022-05-06 2022-05-05 B Purchase
3.6
McKee Kelly T. Jr.

Chief Medical Officer

Officer
9,722 +194.5%
0.72
US$7,000 		9,722 +194.5% 0.72 US$7,000
2022-05-05 2022-05-04 B Purchase
3.6
McKee Kelly T. Jr.

Chief Medical Officer

Officer
4,999 +inf%
0.71
US$3,549 		4,999 +inf% 0.71 US$3,549
2020-09-29 2020-09-29 B Purchase
1.2
CHASE RANDAL D
Non-Executive Director
16,613 +inf%
5.00
US$83,065 		16,613 +inf% 5.00 US$83,065
2020-09-29 2020-09-29 B Purchase
MCNALLY ROBERT T
Non-Executive Director
53,925 +inf%
5.00
US$269,625 		53,925 +inf% 5.00 US$269,625
2020-09-29 2020-09-29 B Purchase
1.9
Reynolds Mark

CFO

Officer
60,184 +inf%
5.00
US$300,920 		60,184 +inf% 5.00 US$300,920
2020-09-29 2020-09-29 B Purchase
1.0
SPENCER JOHN N JR
Non-Executive Director
21,024 +inf%
5.00
US$105,120 		21,024 +inf% 5.00 US$105,120
2020-09-29 2020-09-29 B Purchase
Kollintzas Dean G
Non-Executive Director
11,987 +inf%
5.00
US$59,935 		11,987 +inf% 5.00 US$59,935
2020-09-29 2020-09-29 B Purchase
2.6
DODD DAVID A

President, CEO

Executive Director
81,870 +inf%
5.00
US$409,350 		81,870 +inf% 5.00 US$409,350
2015-05-05 2015-05-05 B Purchase CHASE RANDAL D Non-Executive Director
200 +0.5%
0.19
US$38 		200 +0.5% 0.19 US$38
2015-05-05 2015-05-05 B Purchase CHASE RANDAL D Non-Executive Director
9,800 +32.7%
0.19
US$1,862 		9,800 +32.7% 0.19 US$1,862
2015-04-23 2015-04-23 B Purchase Reynolds Mark

CFO

Officer
10,000 +17.9%
0.18
US$1,780 		10,000 +17.9% 0.18 US$1,780
2015-04-23 2015-04-22 B Purchase Reynolds Mark

CFO

Officer
10,000 +21.7%
0.17
US$1,735 		10,000 +21.7% 0.17 US$1,735
2015-04-23 2015-04-22 B Purchase Reynolds Mark

CFO

Officer
10,000 +27.8%
0.17
US$1,700 		10,000 +27.8% 0.17 US$1,700
2015-04-20 2015-04-20 B Purchase SPENCER JOHN N JR Non-Executive Director
18,000 +62.9%
0.17
US$3,015 		18,000 +62.9% 0.17 US$3,015
2015-04-20 2015-04-20 B Purchase CHASE RANDAL D Non-Executive Director
30,000 +inf%
0.17
US$5,100 		30,000 +inf% 0.17 US$5,100
2012-02-01 2012-01-31 B Purchase Reynolds Mark

CFO

Officer
15,000 +71.4%
0.67
US$10,050 		15,000 +71.4% 0.67 US$10,050
2012-01-17 2012-01-16 B Purchase Antebi Steven S. Non-Executive Director
30,000 +inf%
0.67
US$20,100 		30,000 +inf% 0.67 US$20,100
2012-01-04 2011-12-30 B Purchase MCNALLY ROBERT T

President/CEO

Executive Director
29,850 +inf%
0.67
US$20,000 		29,850 +inf% 0.67 US$20,000
2012-01-04 2011-12-30 B Purchase ROBINSON HARRIET L

Chief Scientific Officer

Executive Director
149,254 +14.2%
0.67
US$100,000 		149,254 +14.2% 0.67 US$100,000
2012-01-04 2011-12-30 B Purchase SPENCER JOHN N JR Non-Executive Director
14,925 +108.9%
0.67
US$10,000 		14,925 +108.9% 0.67 US$10,000
2012-01-04 2011-12-30 B Purchase Kollintzas Dean G Non-Executive Director
14,925 +inf%
0.67
US$10,000 		14,925 +inf% 0.67 US$10,000
2012-01-04 2011-12-30 B Purchase Reynolds Mark

CFO

Officer
15,000 +250.0%
0.67
US$10,050 		15,000 +250.0% 0.67 US$10,050
2012-01-04 2011-12-30 B Purchase DODD DAVID A Non-Executive Director
112,000 +712.2%
0.67
US$75,040 		112,000 +712.2% 0.67 US$75,040
2010-07-06 2010-07-02 B Purchase Reynolds Mark

Chief Financial Officer

Officer
1,000 +20.0%
2.50
US$2,500 		1,000 +20.0% 2.50 US$2,500
2010-06-14 2010-06-11 B Purchase NEWMAN MARK J

VP, Research & Development

Officer
2,000 +200.0%
3.32
US$6,640 		2,000 +200.0% 3.32 US$6,640
2010-06-14 2010-06-11 B Purchase NEWMAN MARK J

VP, Research & Development

Officer
1,000 +inf%
3.25
US$3,250 		1,000 +inf% 3.25 US$3,250
2010-06-14 2010-06-10 B Purchase ROBINSON HARRIET L

Chief Scientific Officer

Executive Director
2,100 +0.2%
3.35
US$7,035 		2,100 +0.2% 3.35 US$7,035
2010-06-11 2010-06-10 B Purchase MCNALLY ROBERT T

President & CEO

Executive Director
300 +3.8%
3.30
US$990 		300 +3.8% 3.30 US$990
2010-06-11 2010-06-10 B Purchase ROBINSON HARRIET L

Chief Scientific Officer

Executive Director
3,000 +0.3%
3.30
US$9,900 		3,000 +0.3% 3.30 US$9,900
2010-06-10 2010-06-09 B Purchase Reynolds Mark

Chief Financial Officer

Officer
530 +11.9%
3.35
US$1,776 		530 +11.9% 3.35 US$1,776
2010-06-10 2010-06-09 B Purchase Reynolds Mark

Chief Financial Officer

Officer
570 +14.6%
3.34
US$1,904 		570 +14.6% 3.34 US$1,904
2010-06-10 2010-06-09 B Purchase MCNALLY ROBERT T

President & CEO

Executive Director
900 +12.7%
3.32
US$2,988 		900 +12.7% 3.32 US$2,988
2010-06-10 2010-06-09 B Purchase Reynolds Mark

Chief Financial Officer

Officer
1,004 +34.7%
3.29
US$3,303 		1,004 +34.7% 3.29 US$3,303
2010-06-10 2010-06-09 B Purchase MCNALLY ROBERT T

President & CEO

Executive Director
100 +1.4%
3.30
US$330 		100 +1.4% 3.30 US$330
2010-06-10 2010-06-09 B Purchase HILDEBRAND DONALD G Non-Executive Director
1,000 +5.6%
3.29
US$3,290 		1,000 +5.6% 3.29 US$3,290
2010-06-10 2010-06-08 B Purchase ROBINSON HARRIET L

Chief Scientific Officer

Executive Director
400 +0.0%
3.23
US$1,290 		400 +0.0% 3.23 US$1,290
2010-06-09 2010-06-08 B Purchase DODD DAVID A Non-Executive Director
3,702 +30.8%
3.25
US$12,032 		3,702 +30.8% 3.25 US$12,032
2010-06-09 2010-06-08 B Purchase DODD DAVID A Non-Executive Director
1,000 +9.1%
3.24
US$3,240 		1,000 +9.1% 3.24 US$3,240
2010-06-09 2010-06-08 B Purchase MCNALLY ROBERT T

President & CEO

Executive Director
1,000 +16.7%
3.25
US$3,250 		1,000 +16.7% 3.25 US$3,250
2010-06-07 2010-06-04 B Purchase ROBINSON HARRIET L

Chief Scientific Officer

Executive Director
3,000 +0.3%
3.30
US$9,900 		3,000 +0.3% 3.30 US$9,900
2010-06-07 2010-06-03 B Purchase ROBINSON HARRIET L

Chief Scientific Officer

Executive Director
500 +0.0%
3.31
US$1,652 		500 +0.0% 3.31 US$1,652
2010-06-03 2010-06-01 B Purchase MCNALLY ROBERT T

President & CEO

Executive Director
1,000 +20.0%
3.49
US$3,490 		1,000 +20.0% 3.49 US$3,490
2010-05-21 2010-05-21 B Purchase MCNALLY ROBERT T

President & CEO

Executive Director
1,000 +25.0%
4.20
US$4,200 		1,000 +25.0% 4.20 US$4,200
2010-05-21 2010-05-21 B Purchase DODD DAVID A Non-Executive Director
2,900 +35.7%
4.00
US$11,600 		2,900 +35.7% 4.00 US$11,600
2010-05-21 2010-05-21 B Purchase DODD DAVID A Non-Executive Director
5,377 +195.8%
3.99
US$21,454 		5,377 +195.8% 3.99 US$21,454
2010-05-21 2010-05-21 B Purchase Tsolinas Peter M Non-Executive Director
2,000 +0.5%
4.10
US$8,200 		2,000 +0.5% 4.10 US$8,200
2010-05-21 2010-05-21 B Purchase MCNALLY ROBERT T

President & CEO

Executive Director
1,000 +33.3%
3.95
US$3,950 		1,000 +33.3% 3.95 US$3,950
2010-05-21 2010-05-21 B Purchase DODD DAVID A Non-Executive Director
88 +3.3%
3.70
US$326 		88 +3.3% 3.70 US$326
2010-05-21 2010-05-20 B Purchase Reynolds Mark

Chief Financial Officer

Officer
796 +37.9%
3.60
US$2,866 		796 +37.9% 3.60 US$2,866
2010-05-20 2010-05-20 B Purchase DODD DAVID A Non-Executive Director
500 +23.2%
3.60
US$1,800 		500 +23.2% 3.60 US$1,800
2010-05-20 2010-05-20 B Purchase DODD DAVID A Non-Executive Director
459 +27.0%
3.55
US$1,629 		459 +27.0% 3.55 US$1,629
2010-05-20 2010-05-20 B Purchase DODD DAVID A Non-Executive Director
500 +41.7%
3.40
US$1,700 		500 +41.7% 3.40 US$1,700
2010-05-20 2010-05-20 B Purchase DODD DAVID A Non-Executive Director
500 +71.5%
3.39
US$1,695 		500 +71.5% 3.39 US$1,695
2010-05-20 2010-05-20 B Purchase MCNALLY ROBERT T

President & CEO

Executive Director
1,000 +50.0%
3.90
US$3,900 		1,000 +50.0% 3.90 US$3,900
2010-05-20 2010-05-20 B Purchase SPENCER JOHN N JR Non-Executive Director
10,100 +280.6%
3.33
US$33,633 		10,100 +280.6% 3.33 US$33,633
Explore more

More insider trading research around GeoVax Labs Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America